Playback speed
10 seconds
ESMO 2024 Insights: Final Analysis of the Phase 3 LITESPARK-005 Study of Belzutifan vs. Everolimus in Patients With Previously Treated Advanced ccRCC
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Brian Rini
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Brian Rini
19 views
September 25, 2024
Login to view comments.
Click here to Login